Open AccessResults and analysis of the application of a consistent targeted therapy in patients with metastatic renal cell carcinoma in Moscow (for the period from June 2005 to July 2015)
Author(s) -
В. И. Широкорад,
Г. П. Колесников,
С. В. Кострицкий,
Kirill Kashintsev,
Д. В. Долгих
Publication year - 2016
Publication title -
onkourologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 4
eISSN - 1996-1812
pISSN - 1726-9776
DOI - 10.17650/1726-9776-2016-12-3-30-39
Subject(s) - sorafenib , pazopanib , sunitinib , medicine , oncology , renal cell carcinoma , targeted therapy , tyrosine kinase inhibitor , combination therapy , progression free survival , overall survival , cancer , hepatocellular carcinoma